Patient Guide: CRISPR-Based Gene Editing Therapy for Retinal Degeneration (NCT03396042) — Editas Medicine

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03396042
Status: 🟢 Enrolling Now
Condition: Retinal Degeneration
Phase: PHASE1, PHASE2, PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily